Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06369753 · ClinicalTrials.gov registry record · NA
Visible Abdominal Distension
A NA study of Irritable Bowel Syndrome and Dyspepsia, sponsored by Hospital Universitari Vall d'Hebron Research Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 7
- Study locations
NCT06369753 is a NA study of Irritable Bowel Syndrome and Dyspepsia that is actively recruiting participants, run by Hospital Universitari Vall d'Hebron Research Institute. The registered enrollment target is 100 participants, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (30% lower). The trial reports 7 study locations across 3 states.
The verdict
NCT06369753, a NA study of Irritable Bowel Syndrome and Dyspepsia, is actively recruiting participants, sponsored by Hospital Universitari Vall d'Hebron Research Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 7
- Study locations
Study Summary
Background. Abdominal distention is produced by an abnormal somatic postural tone. The authors developed an original biofeedback technique. In a randomized, placebo-controlled trial the authors demonstrated the superiority of biofeedback over placebo for the treatment of abdominal distention. However, the technique is technically complex and unpractical. Aim. To prove the efficacy of a noninstrumental biofeedback technique, transmitted by a standard training program, for the treatment of abdominal distension in different centers. Selection criteria. Episodes of visible abdominal distension. Intervention. Patients will be randomized into biofeedback and placebo groups. Three sessions of either biofeedback or placebo intervention will be performed during the first 3 weeks of the intervention period. Biofeedback: Patients will be taught to control abdominal and thoracic muscular activity by providing instructions using an original video support. In each center one operator will receive a standard training on how to deliver the noninstrumental biofeedback treatment. Patients will be instructed to perform the same exercises before and after breakfast, lunch and dinner during the 4-week intervention period. Placebo: Sham measurements of abdominal and thoracic motion will be performed, and a pill of placebo containing 0.21 g glucose will be administered; patients will be instructed to take a pill of placebo before breakfast, lunch and dinner during the 4-week intervention period.
Conditions Studied
Interventions
- BEHAVIORAL Biofeedback
- BEHAVIORAL Placebo
Study Locations (7)
Other
- Bordeaux University Hospital - Bordeaux
- Santa Orsola Hospital - Bologna
- Hospital Universitari Vall d'Hebron - Barcelona
- Sahlgrenska Hospital, Gothenburg - Gothenburg
- Manchester University - Manchester
California
- G. Oppenheimer Center for Neurobiology of Stress and Resilience - Los Angeles
Ontario
- McMaster University - Hamilton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-07-30 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06369753
The ClinicalTrials.gov registry entry for NCT06369753 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (30% lower). The listed sponsor is Hospital Universitari Vall d'Hebron Research Institute, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Biofeedback is the first listed.
NCT06369753 reports 7 study locations spanning 3 distinct geographic areas - top geographies include Other, California, Ontario.
Frequently Asked Questions
What is clinical trial NCT06369753 about?
NCT06369753 is a clinical study titled "Visible Abdominal Distension". Background. Abdominal distention is produced by an abnormal somatic postural tone. The authors developed an original biofeedback technique. In a randomized, placebo-controlled trial the authors demonstrated the superiority of biofeedback over placebo for the treatment of abdominal distention. Howeve...
What is the current status of trial NCT06369753?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-07-30. Estimated completion is 2026-10.
What conditions does trial NCT06369753 study?
This clinical trial studies the following conditions: Irritable Bowel Syndrome, Dyspepsia, Functional Bloating.
What interventions are being tested in trial NCT06369753?
The interventions under investigation include: Biofeedback (BEHAVIORAL), Placebo (BEHAVIORAL).
Who is sponsoring clinical trial NCT06369753?
This trial is sponsored by Hospital Universitari Vall d'Hebron Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06369753 being conducted?
This trial has 7 study locations across California, Ontario. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Irritable Bowel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?
RECRUITING · NA
-
GI Alpha-Gal Study
RECRUITING · NA
-
IBS Skin Patch Test Food Allergy Study
RECRUITING · NA
-
Standardized Yoga & Meditation Program for Stress Reduction for Adolescents With Irritable Bowel Syndrome
RECRUITING · NA
-
Well-being in IBS: Strengths and Happiness (WISH) 2.0
RECRUITING · NA
-
Mechanisms of Gulf War Illness
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.